Miller Fisher syndrome after Pfizer BioNTech vaccine booster responsive to intravenous Ig treatment

BMJ Case Rep. 2022 Nov 10;15(11):e251361. doi: 10.1136/bcr-2022-251361.

Authors

Baibing Chen¹, Sebastian Lopez², Eric Eggenberger²

Affiliations

¹ Department of Neurology, Mayo Clinic in Florida, Jacksonville, Florida, USA baibingchen.yale@gmail.com.
² Department of Neurology, Mayo Clinic in Florida, Jacksonville, Florida, USA.

No abstract available

Keywords: COVID-19; Cranial nerves; Neurology; Neuroopthalmology; Vaccination/immunisation.

Publication types

Case Reports

MeSH terms

Administration, Intravenous
Humans
Immunoglobulins, Intravenous / therapeutic use
Miller Fisher Syndrome* / drug therapy
Vaccination
Vaccines* / therapeutic use

Substances

Immunoglobulins, Intravenous
Vaccines